NIH-funded research R01 grant

SARS-CoV-2, APOE, and dementia: how COVID-19 affects thinking in aging and Alzheimer’s

Official title: Acute and Long-Term Impact of SARS-CoV-2 Infection and its Interaction with APOE on Cognitive Function and Neuropathology in Aging and Alzheimer's Disease

Funded at University of Minnesota · NIH-11370014 · Data updated 2026-11-12

This NIH grant explores how COVID-19 may impact brain function and pathology in people with aging or Alzheimer's disease, including how APOE genes might influence the effects.

More s Disease research and trials

Quick facts

Grant typeR01 grant
Study typeNIH-funded research
Funding institutionUniversity of Minnesota
NIH-funded
Lab location1 site (Minneapolis, United States)
Project startJune 15, 2022
Project endMay 31, 2027
Funding year2026
Award (this year)$700,148
NIH project number5R01AG077772-03
Project IDNIH-11370014 on NIH RePORTER

Who could benefit from this research

Could help

Adults with aging-related cognitive impairment or Alzheimer’s disease, and who have or are at risk for SARS-CoV-2 infection, may be eligible.

Less likely to help

Individuals without cognitive impairment or dementia or those not affected by SARS-CoV-2 infection may have limited direct benefit.

What this research studies

If you or a loved one has aging-related cognitive concerns or Alzheimer’s disease, this project looks at how a COVID-19 infection could affect thinking and brain health over time. The researchers plan to study genetic factors like APOE that may make the brain more vulnerable after infection and to examine changes in brain pathology. By following patients and analyzing brain-related data, the study aims to uncover mechanisms linking SARS-CoV-2 infection to cognitive decline. Results could guide future care strategies for people with dementia who also had COVID-19.

Why it matters

Potential benefit: It could lead to better understanding and management of cognitive symptoms in older adults who have had COVID-19 and dementia.

How similar studies have gone: Early studies show a link between severe COVID-19 and later cognitive issues, but this project seeks to clarify genetic and neuropathological connections.

Where this research is happening

  • University of Minnesota
    Minneapolis, United States
    Active

Researchers

  • Principal investigator: Li, Ling — University of Minnesota
  • Study coordinator: Li, Ling

Related research

Other NIH-funded projects on the same topics.

About this research

  1. This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
  2. Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
  3. For full project details, budget, and progress reports, visit the official NIH RePORTER page.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.